Ayahuasca-inspired DMT/harmine formulation alters creative thinking dynamics during artistic creation
Dila Suay, Helena Dorothea Aicher, Berit Singer, Michael J Mueller, Alen Jelusic, Lionel Calzaferri, Paul Springfeld, Dario Dornbierer, Milan Scheidegger
Universität Zürich, ZORA August 16, 2025 DOI: 10.5167/uzh-284111 via OpenAlex
Summary
AI-generated from the abstractA psychedelic formulation combining DMT and harmine impaired convergent thinking, especially in people with higher baseline reasoning, while harmine alone had no such effect. Divergent thinking showed no overall change, though there were trend-level reductions in fluency and elaboration under the combined formulation. In a real-world painting task, both the combined formulation and harmine alone reduced incubation-related transitions, and the combined formulation uniquely decreased transitions from incubation to illumination, suggesting altered pathways to insight. Subjective experiences like altered meaning perception and increased insightfulness predicted divergent, but not convergent, thinking outcomes. The effects of psychedelics on creativity are not uniform and depend on the cognitive stage and individual differences.
Study at a glance
| Characteristics | Double-blind, placebo-controlled, within-subject design Peer reviewed |
|---|---|
| Sample size | 30 |
| Population | Healthy male participants |
| Interventions | DMT/HAR harmine alone placebo |
| Keywords | Divergent thinking Fluency Perception Dynamics music Task project management |
| Key finding | DMT/HAR impaired convergent thinking and reduced incubation-to-illumination transitions, while subjective experiences predicted divergent thinking outcomes. |
Abstract
Background: While psychedelics are often claimed to enhance creativity, their precise effects on distinct stages of creative cognition remain poorly understood. This study investigated the acute effects of an ayahuasca-inspired formulation combining N,N-dimethyltryptamine (DMT) and harmine (DMT/HAR), as well as harmine alone (HAR), on micro-level (divergent/convergent thinking) and macro-level (creative process dynamics) creativity. Methods: In a double-blind, placebo-controlled, within-subject design, 30 healthy male participants completed three sessions (DMT/HAR, HAR, placebo). Micro-level creativity was assessed using the picture concept task (convergent thinking) and alternative uses task (divergent thinking). Macro-level dynamics were examined through a real-world painting task using the creative process report diary, which captured dynamic stage transitions. Subjective experiences were also recorded to explore their predictive value for creativity. Results: DMT/HAR significantly impaired convergent thinking, particularly in individuals with higher baseline reasoning. Divergent thinking showed no overall effect but revealed trend-level reductions in fluency and elaboration under DMT/HAR. At the macro-level, both DMT/HAR and HAR reduced incubation-related transitions, while DMT/HAR uniquely decreased transitions from incubation to illumination, suggesting altered pathways to insight. Subjective experiences such as altered meaning perception and increased insightfulness selectively predicted divergent, but not convergent, thinking outcomes. Conclusions: This study demonstrates that the effects of DMT/HAR on creativity are not uniform. By capturing real-world creative behavior through an ecologically valid painting task, this study offers the first evidence that psychedelics influence not only creative cognition but also the dynamic processes that give rise to it. These findings highlight the importance of integrating cognitive, phenomenological and process-level perspectives to better understand creative thinking under altered states. Future research should further investigate how individual differences in subjective experience and cognitive style modulate the unfolding of creative processes under psychedelics.